Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,780 shares at $22.80 ($41K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($41k) by SVP, Chief Accounting Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.80 | 1,632 | $37K | 91.5% |
| 2 | $23.39 | 148 | $3K | 8.5% |
| Total | $22.85 avg | 1,780 | $41K | 100% |
| Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |
| RARE | SELL | 2025-09-08 | $3K | — | Filing → |